These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25388328)
1. Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models. Huang H; Zhang P; Chen H; Ji L; Chao H Chemistry; 2015 Jan; 21(2):715-25. PubMed ID: 25388328 [TBL] [Abstract][Full Text] [Related]
2. Novel ruthenium(II) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors. Liao G; Chen X; Wu J; Qian C; Wang H; Ji L; Chao H Dalton Trans; 2014 Jun; 43(21):7811-9. PubMed ID: 24699821 [TBL] [Abstract][Full Text] [Related]
4. Anticancer activity studies of a ruthenium(II) polypyridyl complex against human hepatocellular (BEL-7402) cells. Li W; Han BJ; Yao JH; Jiang GB; Lin GJ; Xie YY; Huang HL; Liu YJ Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():127-34. PubMed ID: 26037497 [TBL] [Abstract][Full Text] [Related]
5. DNA binding, cytotoxicity, and apoptotic-inducing activity of ruthenium(II) polypyridyl complex. Zhang P; Chen J; Liang Y Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):440-9. PubMed ID: 20705582 [TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II) polypyridyl complexes: synthesis and studies of DNA binding, photocleavage, cytotoxicity, apoptosis, cellular uptake, and antioxidant activity. Liu YJ; Liang ZH; Li ZZ; Yao JH; Huang HL DNA Cell Biol; 2011 Oct; 30(10):829-38. PubMed ID: 21395447 [TBL] [Abstract][Full Text] [Related]
7. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives. Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156 [TBL] [Abstract][Full Text] [Related]
8. DNA-binding, photocleavage studies of ruthenium(II) complexes with 2-(2-quinolinyl) imidazo[4,5-f][1,10]phenanthroline. Liu XW; Chen ZG; Li L; Chen YD; Lu JL; Zhang DS Spectrochim Acta A Mol Biomol Spectrosc; 2013 Feb; 102():142-9. PubMed ID: 23220529 [TBL] [Abstract][Full Text] [Related]
9. Protein-binding, cytotoxicity in vitro and cell cycle arrest of ruthenium(II) polypyridyl complexes. Liu SH; Zhu JW; Xu HH; Wang Y; Liu YM; Liang JB; Zhang GQ; Cao DH; Lin YY; Wu Y; Guo QF Spectrochim Acta A Mol Biomol Spectrosc; 2016 May; 161():77-82. PubMed ID: 26956530 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines. Du J; Kang Y; Zhao Y; Zheng W; Zhang Y; Lin Y; Wang Z; Wang Y; Luo Q; Wu K; Wang F Inorg Chem; 2016 May; 55(9):4595-605. PubMed ID: 27093574 [TBL] [Abstract][Full Text] [Related]
11. DNA photofootprinting with Rh(phi)2bpy3+. Klakamp SL; Barton JK Methods Mol Biol; 1994; 31():331-7. PubMed ID: 7921029 [No Abstract] [Full Text] [Related]
12. Anti-tubercular activity of ruthenium (II) complexes with polypyridines. Hadda TB; Akkurt M; Baba MF; Daoudi M; Bennani B; Kerbal A; Chohan ZH J Enzyme Inhib Med Chem; 2009 Apr; 24(2):457-63. PubMed ID: 18608758 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes. Huang HL; Li ZZ; Liang ZH; Yao JH; Liu YJ Eur J Med Chem; 2011 Aug; 46(8):3282-90. PubMed ID: 21570748 [TBL] [Abstract][Full Text] [Related]
14. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents. Liu J; Chen Y; Li G; Zhang P; Jin C; Zeng L; Ji L; Chao H Biomaterials; 2015 Jul; 56():140-53. PubMed ID: 25934287 [TBL] [Abstract][Full Text] [Related]
15. Labile ruthenium(ii) complexes with extended phenyl-substituted terpyridyl ligands: synthesis, aquation and anticancer evaluation. Huang H; Zhang P; Chen Y; Ji L; Chao H Dalton Trans; 2015 Sep; 44(35):15602-10. PubMed ID: 26245234 [TBL] [Abstract][Full Text] [Related]
16. Photophysical properties of ruthenium(II) polypyridyl DNA intercalators: effects of the molecular surroundings investigated by theory. Véry T; Ambrosek D; Otsuka M; Gourlaouen C; Assfeld X; Monari A; Daniel C Chemistry; 2014 Sep; 20(40):12901-9. PubMed ID: 25145959 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Spectral Properties and DFT Calculations of new Ruthenium (II) Polypyridyl Complexes; DNA Binding Affinity and in Vitro Cytotoxicity Activity. Mallepally RR; Chintakuntla N; Putta VR; K N; Vuradi RK; P M; S SS; Chitumalla RK; Jang J; Penumaka N; Sirasani S J Fluoresc; 2017 Jul; 27(4):1513-1530. PubMed ID: 28432633 [TBL] [Abstract][Full Text] [Related]
18. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent. Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884 [TBL] [Abstract][Full Text] [Related]
19. A novel ruthenium(II) arene based intercalator with potent anticancer activity. Ruiz J; Vicente C; de Haro C; Bautista D Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164 [TBL] [Abstract][Full Text] [Related]
20. Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling. Zhao Z; Luo Z; Wu Q; Zheng W; Feng Y; Chen T Dalton Trans; 2014 Dec; 43(45):17017-28. PubMed ID: 25087850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]